Artemether 80mg Injection | Artemisinin Derivative for Severe Malaria

Sinophare-artemether
  • Dosage: Artemether 80mg
  • Volume: 1ml per  Ampoule
  • Packaging: Sterile Ampoules for injection, 6 ampoules/tray*1 box
  • Shelf Life: 36months 

Click to add this item to cart.

Product Description

Product NameArtemether 80mg Injection (Artemether Intramuscular Injection)
SpecificationEach ampoule contains: Artemether 80mg in 1mL (or appropriate volume) sterile oily solution for intramuscular injection
Dosage FormSterile Solution for Intramuscular Injection (IM)
Active IngredientArtemether (Artemisinin Derivative)
Pharmacological ClassAntimalarial Agent (Artemisinin Derivative / Rapid-Acting Blood Schizonticide)
Route of AdministrationIntramuscular (IM) injection only. Do NOT administer intravenously (IV) or by any other route. Administered by healthcare professionals in clinical settings.
PackagingAmpoules (glass), typically 1mL per ampoule; supplied in boxes of 5 or 10 ampoules
StorageStore below 25°C, protected from light. Do not refrigerate or freeze. Keep ampoules in the original carton to protect from light.
Shelf Life36 months (unopened)

Product Overview

Artemether 80mg Injection is a sterile, oily solution of the artemisinin derivative artemether, intended for intramuscular injection. Artemether is a rapid-acting blood schizonticide used for the treatment of severe malaria, particularly when oral therapy is not feasible (e.g., in patients unable to take oral medication due to severe illness, vomiting, or unconsciousness).

Artemether 80mg Injection: What the Published Guidance Says

Artemisinin-based combination therapy is the WHO-recommended backbone of falciparum malaria treatment.

Buyers usually settle three things before ordering Artemether 80mg Injection: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

  • The ACT combinations and their strengths are specified on the WHO Model List Section 6.5.3.1 of the 24th WHO Model List (2025) specifies the curative antimalarials, including artemether + lumefantrine tablet 20 mg + 120 mg and a dispersible tablet, artesunate + amodiaquine, artesunate + mefloquine, artesunate + pyronaridine as granules and tablets, dihydroartemisinin + piperaquine across four tablet strengths, and artesunate co-packaged with sulfadoxine + pyrimethamine. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
  • ACT is the treatment of choice in all trimesters For uncomplicated P. falciparum malaria, MSF medical guidelines state the treatment of choice in all trimesters is an artemisinin-based combination therapy taken for three days. Co-formulated and co-blistered regimens are both described, including artemether/lumefantrine 20/120 mg and 80/480 mg, artesunate/amodiaquine, artesunate/mefloquine and dihydroartemisinin/piperaquine. MSF Medical Guidelines — Malaria (Chapter 4.3, Parasitic infections)
  • For severe malaria, parenteral artesunate is the drug of choice WHO guidance is artesunate 2.4 mg/kg by intravenous or intramuscular injection on admission, again at 12 and 24 hours, then once daily. Where artesunate is unavailable, intramuscular artemether 3.2 mg/kg on admission followed by 1.6 mg/kg daily is the alternative — artemether must never be given by the intravenous route. Parenteral treatment continues for at least 24 hours before switching to a full three-day oral ACT course. WHO — Malaria case management: operations manual

Each point above is reproduced because it has a practical consequence for Artemether 80mg Injection: the strength you can register, the pack you can release, or the wording permitted on the label. Your national prescribing information always takes precedence.

Supply & Specification Data for Artemether 80mg Injection

Product NameArtemether 80mg Injection (Artemether Intramuscular Injection)
SpecificationEach ampoule contains: Artemether 80mg in 1mL (or appropriate volume) sterile oily solution for intramuscular injection
Dosage FormSterile Solution for Intramuscular Injection (IM)
Active IngredientArtemether (Artemisinin Derivative)
Pharmacological ClassAntimalarial Agent (Artemisinin Derivative / Rapid-Acting Blood Schizonticide)
Route of AdministrationIntramuscular (IM) injection only. Do NOT administer intravenously (IV) or by any other route. Administered by healthcare professionals in clinical settings.
StorageStore below 25°C, protected from light. Do not refrigerate or freeze. Keep ampoules in the original carton to protect from light.
Therapeutic groupMalaria & ACTs — Malaria & ACTs
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Quinine Dihydrochloride Injection 2ml:600mg, Artesunate 80mg Powder for Injection, Artesunate Suppositories 100mg, Artesunate 20mg + Pyronaridine 60mg Granules, Chloroquine Phosphate 500mg Tablets, Dihydroartemisinin 40mg + Piperaquine 320mg Tablets, Sulfadoxine/Pyrimethamine 175mg + Amodiaquine 75mg, Sulfadoxine Pyrimethamine 175mg + Dihydroartemisinin 60mg.

Testing, Monographs & Batch Documentation

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Release testing for Artemether 80mg Injection follows the monograph you nominate — USP, EP, BP or CP. If the presentation is not covered by a monograph, the specification is frozen in writing with your quality team before the batch is manufactured.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The batch record for this product normally includes:

  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Pack Configuration, Artwork & Shipping Documents

  • Pack size: Ampoules (glass), typically 1mL per ampoule; supplied in boxes of 5 or 10 ampoules. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store below 25°C, protected from light. Do not refrigerate or freeze. Keep ampoules in the original carton to protect from light..
  • Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Dossier, Authority Filings & Tender Documentation

The legal manufacturer named on every document for Artemether 80mg Injection is Sinophare Bio-technology Co., Ltd., DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. The same entity appears on the GMP certificate and on the dossier submitted to your regulator.

  • Site Master File and GMP certificate for the manufacturing workshops.
  • Method validation, stability protocol and the shelf-life justification for the marketed pack.
  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.

Artemether 80mg Injection is presented here against ACT regimens named in the WHO Model List of Essential Medicines. Inclusion in an essential-medicines list does not authorise sale in any particular country — the marketing authorisation for that market is a separate step.

Buyer Questions about Artemether 80mg Injection

What pack size is available for Artemether 80mg Injection?

Standard commercial packaging for this line is Ampoules (glass), typically 1mL per ampoule; supplied in boxes of 5 or 10 ampoules. Alternative pack sizes are produced to your specification and are supported by the corresponding stability data.

What documentation comes with a shipment of Artemether 80mg Injection?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months.

Does the batch documentation for Artemether 80mg Injection support a registration filing?

The documentation set for every shipment includes the certificate of analysis (description, identification, assay, related substances), stability data for the marketed pack, and the site GMP certificate. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

Which ACT combinations appear on the WHO Model List?

The 24th List (2025) specifies artemether + lumefantrine, artesunate + amodiaquine, artesunate + mefloquine, artesunate + pyronaridine, dihydroartemisinin + piperaquine, artesunate co-packaged with sulfadoxine + pyrimethamine, and chloroquine restricted to P. vivax.

Do you supply dispersible paediatric ACTs?

Yes. We supply dispersible and dry-suspension presentations aligned to the strengths in the Model List, including artemether + lumefantrine 20/120 mg dispersible tablets and paediatric suspensions.

Other Malaria & ACTs Products in This Range

Browse the full Malaria & ACTs range; all Injectables; the complete product catalogue.

Request a Quotation for Artemether 80mg Injection

Tell us the monograph, pack size and quantity required for Artemether 80mg Injection 80mg, together with the destination market, and the quotation will state lead time and the documents that ship with the batch. Samples for registration can be added to the same order.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products